420 related articles for article (PubMed ID: 20488790)
1. Human CD34-derived myeloid dendritic cell development requires intact phosphatidylinositol 3-kinase-protein kinase B-mammalian target of rapamycin signaling.
van de Laar L; Buitenhuis M; Wensveen FM; Janssen HL; Coffer PJ; Woltman AM
J Immunol; 2010 Jun; 184(12):6600-11. PubMed ID: 20488790
[TBL] [Abstract][Full Text] [Related]
2. A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.
Haidinger M; Poglitsch M; Geyeregger R; Kasturi S; Zeyda M; Zlabinger GJ; Pulendran B; Hörl WH; Säemann MD; Weichhart T
J Immunol; 2010 Oct; 185(7):3919-31. PubMed ID: 20805416
[TBL] [Abstract][Full Text] [Related]
3. A nonredundant role for canonical NF-κB in human myeloid dendritic cell development and function.
van de Laar L; van den Bosch A; van der Kooij SW; Janssen HL; Coffer PJ; van Kooten C; Woltman AM
J Immunol; 2010 Dec; 185(12):7252-61. PubMed ID: 21076069
[TBL] [Abstract][Full Text] [Related]
4. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
5. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model.
St Louis DC; Woodcock JB; Franzoso G; Blair PJ; Carlson LM; Murillo M; Wells MR; Williams AJ; Smoot DS; Kaushal S; Grimes JL; Harlan DM; Chute JP; June CH; Siebenlist U; Lee KP
J Immunol; 1999 Mar; 162(6):3237-48. PubMed ID: 10092775
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.
Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW
Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912
[TBL] [Abstract][Full Text] [Related]
7. Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway.
Mattioli B; Giordani L; Quaranta MG; Viora M
FEBS Lett; 2009 Apr; 583(7):1102-6. PubMed ID: 19250936
[TBL] [Abstract][Full Text] [Related]
8. Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.
Martelli AM; Evangelisti C; Chiarini F; Grimaldi C; Manzoli L; McCubrey JA
Expert Opin Investig Drugs; 2009 Sep; 18(9):1333-49. PubMed ID: 19678801
[TBL] [Abstract][Full Text] [Related]
9. Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling.
Davis TA; Saini AA; Blair PJ; Levine BL; Craighead N; Harlan DM; June CH; Lee KP
J Immunol; 1998 Apr; 160(8):3689-97. PubMed ID: 9558069
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
11. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.
Weichhart T; Säemann MD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii70-4. PubMed ID: 19022819
[TBL] [Abstract][Full Text] [Related]
12. Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway.
Markova B; Albers C; Breitenbuecher F; Melo JV; Brümmendorf TH; Heidel F; Lipka D; Duyster J; Huber C; Fischer T
Oncogene; 2010 Feb; 29(5):739-51. PubMed ID: 19881535
[TBL] [Abstract][Full Text] [Related]
13. High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways.
Ryu JM; Lee MY; Yun SP; Han HJ
J Cell Physiol; 2010 Jul; 224(1):59-70. PubMed ID: 20232305
[TBL] [Abstract][Full Text] [Related]
14. PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes.
Wu X; Kihara T; Akaike A; Niidome T; Sugimoto H
Biochem Biophys Res Commun; 2010 Mar; 393(3):514-8. PubMed ID: 20152809
[TBL] [Abstract][Full Text] [Related]
15. PI3K-PKB hyperactivation augments human plasmacytoid dendritic cell development and function.
van de Laar L; van den Bosch A; Boonstra A; Binda RS; Buitenhuis M; Janssen HL; Coffer PJ; Woltman AM
Blood; 2012 Dec; 120(25):4982-91. PubMed ID: 23091295
[TBL] [Abstract][Full Text] [Related]
16. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
17. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells.
Ji J; Zheng PS
Gynecol Oncol; 2010 Apr; 117(1):103-8. PubMed ID: 20102778
[TBL] [Abstract][Full Text] [Related]
18. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
Mungamuri SK; Yang X; Thor AD; Somasundaram K
Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424
[TBL] [Abstract][Full Text] [Related]
19. Tight control of STAT5 activity determines human CD34-derived interstitial dendritic cell and langerhans cell development.
van de Laar L; van den Bosch A; Wierenga AT; Janssen HL; Coffer PJ; Woltman AM
J Immunol; 2011 Jun; 186(12):7016-24. PubMed ID: 21602494
[TBL] [Abstract][Full Text] [Related]
20. mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.
Turnquist HR; Cardinal J; Macedo C; Rosborough BR; Sumpter TL; Geller DA; Metes D; Thomson AW
Blood; 2010 Jun; 115(23):4758-69. PubMed ID: 20335217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
